Dividend Assets Capital, LLC Abbott Laboratories Transaction History

Dividend Assets Capital, LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $26,503 - $29,272	242 Added 13.89%	1,984 $226,000
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $11,363 - $13,910	-126 Reduced 6.75%	1,742 $192,000
Q3 2023 Oct 26, 2023	SELL	$95.53 - $114.62 $1,241 - $1,490	-13 Reduced 0.69%	1,868 $181,000
Q2 2023 Jul 31, 2023	SELL	$100.78 - $112.29 $21,466 - $23,917	-213 Reduced 10.17%	1,881 $205,000
Q3 2022 Oct 18, 2022	SELL	$96.76 - $112.03 $870 - $1,008	-9 Reduced 0.43%	2,094 $203,000
Q2 2022 Jul 15, 2022	BUY	$102.07 - $123.37 $9,798 - $11,843	96 Added 4.78%	2,103 $228,000
Q1 2022 Apr 12, 2022	BUY	$114.02 - $139.04 $25,198 - $30,727	221 Added 12.37%	2,007 $238,000
Q3 2021 Nov 01, 2021	SELL	$116.66 - $129.06 $23,332 - $25,812	-200 Reduced 10.07%	1,786 $211,000
Q1 2021 Apr 28, 2021	SELL	$108.84 - $128.23 $1,523 - $1,795	-14 Reduced 0.7%	1,986 $238,000
Q4 2020 Jan 22, 2021	SELL	$105.0 - $114.42 $96,495 - $105,151	-919 Reduced 31.48%	2,000 $219,000
Q2 2020 Aug 03, 2020	SELL	$76.57 - $98.0 $27,258 - $34,888	-356 Reduced 10.87%	2,919 $267,000
Q1 2020 May 12, 2020	SELL	$62.82 - $91.86 $44,979 - $65,771	-716 Reduced 17.94%	3,275 $258,000
Q4 2019 Feb 10, 2020	SELL	$78.51 - $87.4 $77,332 - $86,089	-985 Reduced 19.8%	3,991 $347,000
Q3 2018 Nov 05, 2018	BUY	$60.81 - $73.36 $8,270 - $9,976	136 Added 2.81%	4,976 $365,000
Q1 2018 May 02, 2018	SELL	$56.27 - $63.62 $19,694 - $22,267	-350 Reduced 6.74%	4,840 $290,000
Q3 2017 Nov 06, 2017	BUY	$48.06 - $53.64 $249,431 - $278,391	5,190	5,190 $277,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $207B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Dividend Assets Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Dividend Assets Capital, LLC with notifications on news.